dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Hyaline Membrane Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (86.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Hifzi, I; Khan, M; Majeed-Saidan, MA | 1 |
| Chatfield, SL; Dear, PR; Kelly, EJ | 1 |
| Cotton, RB; Law, AB; Lindstrom, DP; Olsson, T; Parker, RA; Sandberg, K; Silberberg, AR; Sundell, HW | 1 |
| Diwaker, K; John, E; Roberts, S | 1 |
| Malathi, I; Ng, KC | 1 |
| Choukroun, ML; Demarquez, JL; Fayon, M; Galpérine, I; Guénard, H; Kays, C; Todd, DA | 1 |
| Bastida, J; Del Barco, M; Grandzoto, J; Hayward, PE; Margotto, P; Martell, M; Peña, J; Rossello, JD; Villanueva, D | 1 |
| Iarŭkova, N | 1 |
| McMillan, DD; Schürch, S; Shukla, AK; Singhal, N | 1 |
| Dobner, M; Helbich, TH; Herold, CJ; Popow, C; Wunderbaldinger, P; Zekert, M | 1 |
| Frey, B; Keller, E; Losa, M | 1 |
| Bogdanova, V; Chernookova, V; Efremova, R; Nedeva, N; Tsvetkova, S | 1 |
| Dutta, S; Kumar, P; Kumar, R; Narang, A | 1 |
| Aebi, C; Bachmann, D; Pfenninger, J; Wagner, BP | 1 |
| Ballard, RA; Clements, JA; Heilbron, DC; Phibbs, CS; Phibbs, RH; Schlueter, MA; Sniderman, SH; Tooley, WH; Wakeley, A | 1 |
5 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Hyaline Membrane Disease
| Article | Year |
|---|---|
The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Topics: Biological Products; Birth Weight; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hyaline Membrane Disease; Hydrogen-Ion Concentration; Infant, Newborn; Infant, Premature; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Function Tests | 1993 |
Respiratory mechanics before and after late artificial surfactant rescue.
Topics: Age Factors; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Mechanics | 1995 |
Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
Topics: Birth Weight; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant Mortality; Infant, Newborn; Infant, Premature; Intensive Care, Neonatal; Latin America; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Retrospective Studies | 1997 |
Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
Topics: Double-Blind Method; Drug Combinations; Exudates and Transudates; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Surface Tension; Trachea | 1998 |
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow-Up Studies; Humans; Hyaline Membrane Disease; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Recurrence; Regression Analysis; Respiration, Artificial; Time Factors | 1991 |
10 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Hyaline Membrane Disease
| Article | Year |
|---|---|
Pulmonary haemorrhage in low-birthweight babies.
Topics: Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Hyaline Membrane Disease; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants | 1993 |
Adverse experiences in an Exosurf treated group.
Topics: Case-Control Studies; Drug Combinations; Fatty Alcohols; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Treatment Outcome | 1994 |
Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neonatal intensive care resource utilization.
Topics: Case-Control Studies; Drug Combinations; Fatty Alcohols; Hospital Costs; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; New South Wales; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial | 1993 |
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemodynamics; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Ventilation; Remission Induction; Respiration, Artificial; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ventilation-Perfusion Ratio | 1995 |
[The effect of surfactant therapy on the oxygen treatment of premature infants with HMD].
Topics: Analysis of Variance; Biological Products; Combined Modality Therapy; Drug Combinations; Drug Evaluation; Fatty Alcohols; Gestational Age; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Oxygen Inhalation Therapy; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Retrospective Studies | 1998 |
New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
Topics: Bronchopulmonary Dysplasia; Case-Control Studies; Drug Combinations; Fatty Alcohols; Female; High-Frequency Ventilation; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Respiration, Artificial; Survival Rate; Treatment Outcome | 1998 |
Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
Topics: Drug Combinations; Electroencephalography; Fatty Alcohols; Follow-Up Studies; Humans; Hyaline Membrane Disease; Infant, Newborn; Infusions, Intravenous; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Seizures; Umbilical Veins | 1999 |
[Surfactant therapy in newborns with hyaline membrane disease].
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Hyaline Membrane Disease; Infant, Low Birth Weight; Infant, Newborn; Infant, Very Low Birth Weight; Intermittent Positive-Pressure Ventilation; Oxygen Inhalation Therapy; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Retrospective Studies | 2000 |
Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants | 2001 |
Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf)
Topics: Carbon Dioxide; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Gas Exchange; Pulmonary Surfactants; Respiration, Artificial; Respiratory Mechanics | 1992 |